Patrick Lin - Apr 5, 2024 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Apr 5, 2024
Transactions value $
-$1,967
Form type
4
Date filed
8/2/2024, 05:28 PM
Previous filing
Feb 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1.68K +6.08% 29.2K Apr 5, 2024 Direct F1
transaction PCSA Common Stock Tax liability -$1.5K -539 -1.84% $2.79 28.7K Apr 5, 2024 Direct
transaction PCSA Common Stock Options Exercise +644 +2.24% 29.3K Jul 10, 2024 Direct F1
transaction PCSA Common Stock Tax liability -$463 -271 -0.92% $1.71 29.1K Jul 10, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +2.71K +13.92% $0.00 22.2K Jun 28, 2024 Common Stock 2.71K $0.00 Direct F2
transaction PCSA Restricted Stock Units Award $0 +2.04K +9.17% $0.00 24.2K Jun 28, 2024 Common Stock 2.04K $0.00 Direct F3
transaction PCSA Restricted Stock Units Award $0 +339 +1.4% $0.00 24.6K Jun 28, 2024 Common Stock 339 $0.00 Direct F4
transaction PCSA Restricted Stock Units Award $0 +339 +1.38% $0.00 24.9K Jun 28, 2024 Common Stock 339 $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of vested restricted shares.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals.